TrialVoclosporin in Adolescent and Pediatric Subjects With Lupus Nephritis
Trial details
- Registry ID
- NCT05288855
- Phase
- Phase 3
AUPH
Aurinia Pharmaceuticals Inc.
Company identity checked against sources
Browse linked trials and recorded changes, or follow this company for updates.
2Trials in this database
10Recorded changes · last 12 months
Partial coverageOnly the trials and history collected so far
Research sample: selected versions from May 2023 onward plus a preceding baseline where available. Only selected fields were retained; endpoint measures were truncated to 300 characters. This is not complete trial or sponsor history. Daily snapshots begin when collection starts.
Completion dates · Pro
Which trial dates moved later?
Pro summarizes how far estimated completion dates moved later and counts trials with edits to their main study measures, using the history available here. View Pro features
Included trials
Check company identity source| Trial | Sponsor | Phase | Status | Primary completion |
|---|---|---|---|---|
| Voclosporin in Adolescent and Pediatric Subjects With Lupus NephritisNCT05288855 | AUPH | Phase 3 | Terminated | 2025-07-03Actual |
| Long-Term Voclosporin Treatment in Adolescent and Pediatric Subjects With Lupus NephritisNCT05962788 | AUPH | Phase 3 | Terminated | 2025-07-04Actual |
Long-Term Voclosporin Treatment in Adolescent and Pediatric Subjects With Lupus Nephritis
Trial details
- Registry ID
- NCT05962788
- Phase
- Phase 3
Latest recorded trial changes
Long-Term Voclosporin Treatment in Adolescent and Pediatric Subjects With Lupus Nephritis
NCT05962788 · Aurinia Pharmaceuticals Inc.
Participant count type changed
− Before
Estimated
+ After
Actual
Enrollment · participant count changed
− Before
40 participants (planned)
+ After
4 participants (actual)
Completion date type changed
− Before
Estimated
+ After
Actual
Primary completion date changed
− Before
Dec 2028
+ After
4 Jul 2025
Recruitment status changed
− Before
Enrolling by invitation
+ After
Terminated
Voclosporin in Adolescent and Pediatric Subjects With Lupus Nephritis
NCT05288855 · Aurinia Pharmaceuticals Inc.
Participant count type changed
− Before
Estimated
+ After
Actual
Enrollment · participant count changed
− Before
40 participants (planned)
+ After
9 participants (actual)
Completion date type changed
− Before
Estimated
+ After
Actual
Primary completion date changed
− Before
Dec 2027
+ After
3 Jul 2025
Recruitment status changed
− Before
Recruiting
+ After
Terminated